Active, Not Recruiting
A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies
NCT05885555
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Med Center Boston, Massachusetts, United States
- Novartis Investigative Site CABA, Argentina
- Novartis Investigative Site Garran, Australian Capital Territory, Australia